Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
531 News Items found
Pictured: Scott Armstrong, Kornelia Polyak & Victor Velculescu
Paul Marks Prize Honors Young Investigators for Promising Cancer Research

Memorial Sloan Kettering Cancer Center feted three gifted young investigators for their insightful contributions to cancer research in a public symposium on December 1, 2011.
In the Lab
Pictured: Timothy Chan
Studies Show How Certain Gene Mutations May Promote Cancer

Two Memorial Sloan Kettering studies provide new clues about genetic mutations that affect cell behavior and play a role in several types of cancer.
Q&A
Pictured: Ion Channel K2P1
3D Shape of an Ion Channel Revealed

Structural biologist Stephen Long talks about how his team used x-ray crystallography to discover the structure of an ion channel called K2P1.
In the News
Pictured: Memorial Sloan Kettering logo
Memorial Sloan Kettering Made Major Contributions to Cancer Advances in 2011

Two of the year's top five cancer research advances cited by the American Society of Clinical Oncology were led by Memorial Sloan Kettering investigators.
In the Lab
Pictured: Eric Pamer
Researchers Shed Light on Possible Cause of Infections in Cancer Patients

Infections are a common cause of complications in cancer patients. Now a Memorial Sloan Kettering research team finds that a commonly prescribed antibiotic could increase susceptibility to a bacterial infection.
In the Clinic
Pictured: Michael Morris
Bone Scan Index May Help Determine Response to Prostate Cancer Treatment

Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.
Honors
Five Memorial Sloan Kettering researchers have been named to Stand Up To Cancer's new Melanoma "Dream Team."
Memorial Sloan Kettering Researchers Appointed to Stand Up To Cancer Melanoma “Dream Team”

Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.
In the Lab
Pictured: Structural formula of IBNtxA
Findings Could Lead to the Development of a New Painkiller

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
In the Lab
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Profile
Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.